{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:27:07Z","timestamp":1790684827688,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.crohns.2011.10.007","type":"journal-article","created":{"date-parts":[[2011,11,13]],"date-time":"2011-11-13T16:57:37Z","timestamp":1321203457000},"page":"518-523","source":"Crossref","is-referenced-by-count":83,"title":["Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases"],"prefix":"10.1093","volume":"6","author":[{"given":"Iv\u00e1n","family":"Guerra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Algaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L\u00e1zaro","family":"P\u00e9rez-Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mar\u00edn-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Garc\u00eda-Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yago","family":"Gonz\u00e1lez-Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"L\u00f3pez-Sanrom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noem\u00ed","family":"Mance\u00f1ido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Mart\u00ednez-Montiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Quintanilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Taxonera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Villafruela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Romero-Mat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"L\u00f3pez-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier P.","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"issue":"6","key":"10.1016\/j.crohns.2011.10.007_bb0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ibd.20107","article-title":"Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients","volume":"13","author":"Spoettl","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.crohns.2011.10.007_bb0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.crohns.2011.10.007_bb0015","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1159\/000320413","article-title":"State-of-the-art: immunosuppression and biologic therapy","volume":"28","author":"Sandborn","year":"2010","journal-title":"Dig Dis"},{"issue":"2","key":"10.1016\/j.crohns.2011.10.007_bb0020","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4049\/jimmunol.1090051","article-title":"Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us?","volume":"185","author":"Feldmann","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.crohns.2011.10.007_bb0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/09546630802441234","article-title":"Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases","volume":"20","author":"Ko","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.crohns.2011.10.007_bb0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/00365528909091339","article-title":"Classification of inflammatory bowel disease","volume":"170","author":"Lennard-Jones","year":"1989","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"Suppl A","key":"10.1016\/j.crohns.2011.10.007_bb0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"issue":"2","key":"10.1016\/j.crohns.2011.10.007_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archderm.143.2.223","article-title":"Psoriasis and pustular dermatitis triggered by TNF-alpha inhibitors in patients with rheumatologic conditions","volume":"143","author":"de Gannes","year":"2007","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.crohns.2011.10.007_bb0045","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ibd.21417","article-title":"Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts","volume":"17","author":"Peyrin-Biroulet","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.crohns.2011.10.007_bb0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5021\/ad.2010.22.2.212","article-title":"A case of tumor necrosis factor-alpha inhibitors-induced pustular psoriasis","volume":"22","author":"Park","year":"2010","journal-title":"Ann Dermatol"},{"issue":"5","key":"10.1016\/j.crohns.2011.10.007_bb0055","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2133.2009.09505.x","article-title":"British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009","volume":"161","author":"Smith","year":"2009","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.crohns.2011.10.007_bb0060","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN-alpha in autoimmune diseases","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.crohns.2011.10.007_bb0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.crohns.2011.10.007_bb0070","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/art.21233","article-title":"Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction","volume":"52","author":"Sfikakis","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.crohns.2011.10.007_bb0075","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ard.62.9.829","article-title":"Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?","volume":"62","author":"Baeten","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.crohns.2011.10.007_bb0080","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","article-title":"Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists","volume":"156","author":"Lee","year":"2007","journal-title":"Br J Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.crohns.2011.10.007_bb0085","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1086\/429998","article-title":"Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?","volume":"41","author":"Ehlers","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.crohns.2011.10.007_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/09546630902882089","article-title":"Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: a \u2018class effect\u2019 of TNF-alpha antagonists or simply an anti-psoriatic treatment adverse reaction?","volume":"21","author":"Rallis","year":"2010","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.crohns.2011.10.007_bb0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/ard.2007.087288","article-title":"Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"68","author":"Harrison","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.crohns.2011.10.007_bb0100","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2010.07.022","article-title":"Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy","volume":"8","author":"Rahier","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.crohns.2011.10.007_bb0105","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","article-title":"The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study","volume":"129","author":"Bernstein","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.crohns.2011.10.007_bb0110","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.autrev.2006.10.001","article-title":"Gender and autoimmunity","volume":"6","author":"Zandman-Goddard","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.crohns.2011.10.007_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.crohns.2010.11.001","article-title":"Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect","volume":"5","author":"Iborra","year":"2011","journal-title":"J Crohns Colitis"},{"issue":"5","key":"10.1016\/j.crohns.2011.10.007_bb0120","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1525-1470.2010.01267.x","article-title":"Occurrence of pustular psoriasis after treatment of Crohn disease with infliximab","volume":"27","author":"Pourciau","year":"2010","journal-title":"Pediatr Dermatol"},{"issue":"10","key":"10.1016\/j.crohns.2011.10.007_bb0125","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/ibd.20450","article-title":"Guttate psoriasis induced by infliximab in a child with Crohn's disease","volume":"14","author":"Costa-Romero","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.crohns.2011.10.007_bb0130","first-page":"278","article-title":"Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease","volume":"70","author":"Avila Alvarez","year":"2009","journal-title":"An Pediatr (Barc)"},{"issue":"1","key":"10.1016\/j.crohns.2011.10.007_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00128071-200809010-00001","article-title":"Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients","volume":"9","author":"Wollina","year":"2008","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"10.1016\/j.crohns.2011.10.007_bb0140","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2036.2009.03955.x","article-title":"Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease","volume":"29","author":"Fiorino","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl III","key":"10.1016\/j.crohns.2011.10.007_bb0145","first-page":"A1","article-title":"Anti-TNF induced cutaneous lesions in IBD patients: characterization and search for predisposing factors","volume":"59","author":"Cleynen","year":"2010","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.crohns.2011.10.007_bb0150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0001-7310(10)70018-1","article-title":"Psoriasiform skin reactions during treatment with etanercept","volume":"101","author":"Santos-Juanes","year":"2010","journal-title":"Actas Dermosifiliogr"},{"issue":"7","key":"10.1016\/j.crohns.2011.10.007_bb0155","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/art.23835","article-title":"Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action","volume":"59","author":"Collamer","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.crohns.2011.10.007_bb0160","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-2133.1998.02113.x","article-title":"Palmoplantar pustulosis: a clinical and immunohistological study","volume":"138","author":"Eriksson","year":"1998","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.crohns.2011.10.007_bb0165","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1365-2133.2005.06977.x","article-title":"Infliximab can precipitate as well as worsen palmoplantar pustulosis: possible linkage to the expression of tumour necrosis factor-alpha in the normal palmar eccrine sweat duct?","volume":"153","author":"Michaelsson","year":"2005","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.crohns.2011.10.007_bb0170","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/SMJ.0b013e3181bb554c","article-title":"Adverse cutaneous reactions induced by TNF-alpha antagonist therapy","volume":"102","author":"Borras-Blasco","year":"2009","journal-title":"South Med J"},{"issue":"6","key":"10.1016\/j.crohns.2011.10.007_bb0185","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/DAD.0b013e3181cb3ff7","article-title":"Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-alpha inhibitor therapy. a study of 16 biopsies","volume":"32","author":"Laga","year":"2010","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"10.1016\/j.crohns.2011.10.007_bb0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semarthrit.2010.04.003","article-title":"Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis","volume":"40","author":"Collamer","year":"2010","journal-title":"Semin Arthritis Rheum"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994611002947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994611002947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/6\/5\/518\/7093795\/6-5-518.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T09:35:32Z","timestamp":1503567332000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2011.10.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1873994611002947"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2011.10.007","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}